Speakers
David Cipolla
VP of Research
Insmed
Day One
Wednesday July 20, 2022
3:45 pm | Formulation & Delivery Challenges with Inhaled Lipid Nanoparticle Formulations
Vincent Nebot
Chief Technical Officer
Polypeptide Therapeutic Solutions (PTS)
Day One
Wednesday July 20, 2022
11:30 am | Polymer Lipid Hybrids: A Chemical Toolbox for LNP Formulations
Bryant Nelson
Staff Research Chemist
National Institute of Standards & Technology
Dr. Shan Zou
Senior Research Officer, Team Leader for Nanoscale Measurement Disciplines; Adjunct Professor of Chemistry
Metrology Research Centre of the National Research Council Canada (NRC); Carleton University
Senior Representative
Precision Nanosystems
Day One
Wednesday July 20, 2022
12:10 pm | Session Reserved for: Precision Nanosystem
Priya Karmali
Chief Technology Officer
Capstan Therapeutics
Day One
Wednesday July 20, 2022
4:45 pm | Closing Remarks & End of Day One
11:00 am | Developing Targeted Lipid Nanoparticles (tLNPs) to Enable Off-the-Shelf Immunotherapies
8:50 am | Opening Remarks
John Lewis
Founder & Chief Executive Officer
Entos Pharmaceuticals
Day Two
Thursday 21 July 2022
10:00 am | Fireside Chat
9:00 am | Exploring a Next-Gen Delivery Platform for Targeted Delivery: Fusogenix Proteo-Lipid Vehicle (PLV)
Chun-Wan Yen
Principal Scientist
Genentech
Day Two
Thursday 21 July 2022
1:15 pm | Predictive High-Throughput Screening of Oligonucleotide Lipid Nanoparticles
Cory Sago
Senior Director & Head of LNP Discovery
Beam Therapeutics
Day Two
Thursday 21 July 2022
10:00 am | Fireside Chat
9:30 am | Multiplexed Screening of LNPs in Vivo Enabled by Nucleic Acid Barcoding
Dominik Witzigmann
Co-Founder & Chief Executive Officer
Nanovation Therapeutics
Day One
Wednesday July 20, 2022
4:45 pm | Closing Remarks & End of Day One
11:40 am | Next-Generation Lipid Nanoparticle Technologies Enabling (Extra) Hepatic Nucleic Acid Delivery
8:50 am | Opening Remarks
Hemant Kumar
Chief Technology & Manufacturing Officer
Genprex
Day Two
Thursday 21 July 2022
2:15 pm | Challenges in Translating Innovative Gene Therapy Drug Targets for Accelerated Development & IND/BLA Submissions
Hila Epstein-Barash
Chief Research & Development Officer
Azura Ophthalmics
Day One
Wednesday July 20, 2022
1:30 pm | Panel Discussion: Delivering Novel Treatments through Lipid-Based NPs Beyond Liver
James Ferguson
Chief Medical Officer
Matinas BioPharma
Day One
Wednesday July 20, 2022
9:30 am | Expanding Current Capabilities for Intracellular Drug Delivery with a Lipid Nano-Crystal (LNC) Platform
Day Two
Thursday 21 July 2022
10:00 am | Fireside Chat
Kalina Paunovska
Postdoctoral Scholar Dahlman Lab
Georgia Institute of Technology
Day One
Wednesday July 20, 2022
2:15 pm | Using High-Throughput LNP Screening to Identify Novel Non-Liver Delivery Vehicles
Ruchi Shah
Associate Director, New Therapeutic Modalities
Eli Lily
Day Two
Thursday 21 July 2022
11:30 am | Roundtable Discussion: Improving Cross-Functional Collaboration
Kristina Friis
Senior Scientist, Advanced Drug Delivery
AstraZeneca
Day One
Wednesday July 20, 2022
4:15 pm | Spray Drying of Lipid Nanoparticles Enables Intratracheal Delivery
Sonya Zabludoff
Vice President, Clinical Development
Nitto BioPharma
Day Two
Thursday 21 July 2022
1:45 pm | Elevating Clinical Design for a Lipid Nanoparticle Candidate
Manuel Sanchez-Felix
Senior Fellow, Novel Delivery Technologies
Novartis
Day Two
Thursday 21 July 2022
11:30 am | Roundtable Discussion: Improving Cross-Functional Collaboration
Qiaobing Xu
Founder & Chief Executive Officer
Hopewell Therapeutics
Rajesh Shinde
Senior Director of Manufacturing & Technology Operations
Genprex
Day One
Wednesday July 20, 2022
9:10 am | From Liposomes to LNPs: Evaluating the Lipid-Based Delivery Technology Landscape
Xiuling Lu
Associate Professor
University of Connecticut